Lu Yu

3.0k total citations · 1 hit paper
82 papers, 2.1k citations indexed

About

Lu Yu is a scholar working on Molecular Biology, Epidemiology and Neurology. According to data from OpenAlex, Lu Yu has authored 82 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Epidemiology and 19 papers in Neurology. Recurrent topics in Lu Yu's work include Autophagy in Disease and Therapy (22 papers), Alzheimer's disease research and treatments (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Lu Yu is often cited by papers focused on Autophagy in Disease and Therapy (22 papers), Alzheimer's disease research and treatments (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Lu Yu collaborates with scholars based in China, Macao and United States. Lu Yu's co-authors include Anguo Wu, Jianming Wu, Dalian Qin, Xiaogang Zhou, Betty Yuen Kwan Law, Yong Tang, Chong‐Lin Yu, Junrong Du, Xi Kuang and Wenqiao Qiu and has published in prestigious journals such as Nature Communications, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Lu Yu

79 papers receiving 2.1k citations

Hit Papers

Macrophage cell membrane-based nanoparticles: a new promi... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment
    2022 164 citations Xiaogang Zhou, Lu Yu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Yu China 27 898 480 374 275 251 82 2.1k
Dalian Qin China 27 1.0k 1.1× 251 0.5× 390 1.0× 294 1.1× 218 0.9× 93 2.2k
Weizu Li China 31 1.1k 1.3× 401 0.8× 353 0.9× 210 0.8× 311 1.2× 88 2.3k
Seyed Esmaeil Khoshnam Iran 23 1.0k 1.1× 648 1.4× 214 0.6× 266 1.0× 145 0.6× 67 2.1k
Syed Shadab Raza India 31 1.0k 1.2× 419 0.9× 332 0.9× 174 0.6× 352 1.4× 78 2.9k
Md. Jakaria Bangladesh 21 892 1.0× 305 0.6× 331 0.9× 117 0.4× 221 0.9× 66 2.0k
Zhao Zhang China 26 791 0.9× 483 1.0× 201 0.5× 227 0.8× 127 0.5× 61 1.6k
Yun Seon Song South Korea 26 856 1.0× 490 1.0× 235 0.6× 150 0.5× 207 0.8× 59 2.4k
Kyoung‐jin Min South Korea 33 1.6k 1.8× 516 1.1× 232 0.6× 321 1.2× 259 1.0× 108 3.2k

Countries citing papers authored by Lu Yu

Since Specialization
Citations

This map shows the geographic impact of Lu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yu more than expected).

Fields of papers citing papers by Lu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yu. The network helps show where Lu Yu may publish in the future.

Co-authorship network of co-authors of Lu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Yu. A scholar is included among the top collaborators of Lu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Yu. Lu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Xiaoqian, Lu Yu, Jianming Wu, et al.. (2025). NAD+ supplementation augments the efficacy of the PARP1 inhibitor PJ34 in a 6-OHDA-induced model of Parkinson’s disease. Genes & Diseases. 13(2). 101783–101783.
4.
Qin, Dalian, Xiaogang Zhou, Lu Yu, et al.. (2025). Prosapogenin CP4 exacerbates mitophagy to induce apoptosis via AMPK-mTOR and PINK1/Parkin pathways in A549 cells. Phytomedicine. 148. 157333–157333. 1 indexed citations
5.
Guo, Minsong, Xiaogang Zhou, Chong‐Lin Yu, et al.. (2025). Ciliatoside A attenuates neuroinflammation in Alzheimer's disease by activating mitophagy and inhibiting NLRP3 inflammasome activation. Phytomedicine. 145. 156928–156928. 2 indexed citations
6.
Zhu, Yunfei, Haijun Fu, Yaping Li, et al.. (2025). Tricin Delays Aging and Enhances Muscle Function via Activating AMPK-Mediated Autophagy in Diverse Model Organisms. Journal of Agricultural and Food Chemistry. 73(17). 10246–10264. 2 indexed citations
7.
Fan, Dongsheng, Minsong Guo, Lu Yu, et al.. (2024). Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimerʼs disease. Phytomedicine. 127. 155463–155463. 13 indexed citations
8.
Guo, Changming, et al.. (2024). Dendrobium officinale polysaccharide alleviates thiacloprid‐induced kidney injury in quails via activating the Nrf2/HO ‐1 pathway. Environmental Toxicology. 39(5). 2655–2666. 3 indexed citations
9.
10.
Li, Xiaoqian, Xiaogang Zhou, Lu Yu, et al.. (2024). Hederagenin inhibits mitochondrial damage in Parkinson’s disease via mitophagy induction. Free Radical Biology and Medicine. 224. 740–756. 8 indexed citations
11.
12.
Yu, Lu, Zhanjun Lv, Siyu Li, et al.. (2023). Chronic arsenic exposure induces ferroptosis via enhancing ferritinophagy in chicken livers. The Science of The Total Environment. 890. 164172–164172. 39 indexed citations
13.
Fu, Haijun, Yaping Li, Dalian Qin, et al.. (2023). The Protective Effects of Reineckia carnea Ether Fraction against Alzheimer’s Disease Pathology: An Exploration in Caenorhabditis elegans Models. International Journal of Molecular Sciences. 24(22). 16536–16536. 5 indexed citations
14.
Qin, Dalian, Xiaohui Su, Lu Yu, et al.. (2023). Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease. CNS Neuroscience & Therapeutics. 30(4). e14515–e14515. 10 indexed citations
15.
Wu, Anguo, Jianming Wu, Yong Tang, et al.. (2022). Targeting Nrf2‐Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals. Oxidative Medicine and Cellular Longevity. 2022(1). 1015791–1015791. 58 indexed citations
16.
Tang, Yong, Changlong He, Lu Yu, et al.. (2022). Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in C. elegans and Cellular Models of Parkinson’s Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 3723567–3723567. 43 indexed citations
17.
Li, Peng, Guangqiang Hu, Jianming Wu, et al.. (2022). Microglia autophagy in ischemic stroke: A double-edged sword. Frontiers in Immunology. 13. 1013311–1013311. 59 indexed citations
18.
Wang, Xiaoli, Jingkang Guo, Zhiping Zhang, et al.. (2020). Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond. Frontiers in Neuroscience. 13. 1393–1393. 70 indexed citations
19.
Li, Chen, et al.. (2017). GW28-e0894 Impaired autophagosome clearance triggers myocardial necroptosis in ischemia/reperfusion injury. Journal of the American College of Cardiology. 70(16). C33–C33. 1 indexed citations
20.
Yu, Lu, et al.. (2006). Experimental study on hypotensive effects of Cinnamaldehyde in anesthetized rats. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dalian Qin Breakdown of academic impact, for papers by Weizu Li Breakdown of academic impact, for papers by Seyed Esmaeil Khoshnam Breakdown of academic impact, for papers by Syed Shadab Raza Breakdown of academic impact, for papers by Md. Jakaria Breakdown of academic impact, for papers by Zhao Zhang Breakdown of academic impact, for papers by Yun Seon Song Breakdown of academic impact, for papers by Kyoung‐jin Min
Rankless by CCL
2026